Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sujun Han"'
Autor:
Weiyu Zhang, Huixin Liu, Ming Liu, Shi Ying, Renbin Yuan, Hao Zeng, Zhenting Zhang, Sujun Han, Zhannan Si, Bin Hu, Simeng Wen, Pengcheng Xu, Weimin Yu, Hui Chen, Liang Wang, Zhitao Lin, Tao Dai, Yunzhi Lin, Tao Xu, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 11, Pp 1324-1331 (2024)
Abstract. Background:. Cardiovascular disease (CVD) has emerged as the leading cause of death from prostate cancer (PCa) in recent decades, bringing a great disease burden worldwide. Men with preexisting CVD have an increased risk for major adverse c
Externí odkaz:
https://doaj.org/article/4dc90a2c3fe64c0da0b05c19c368e19d
Autor:
Sujun Han, Yu Xu, Dong Chen, Feiya Yang, Mingshuai Wang, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Chunwei Xu, Wenxian Wang, Shangli Cai, Nianzeng Xing
Publikováno v:
iScience, Vol 27, Iss 1, Pp 108290- (2024)
Summary: The evolutionarily conserved Notch pathway, involved in cancer stem cell capacity and cancer immunity, may predict the benefit from immune checkpoint inhibitors (ICIs) in clear cell renal cell carcinoma (ccRCC). In the TCGA dataset, mRNA exp
Externí odkaz:
https://doaj.org/article/9f0b266ea75c42bd9eab268846484edc
Autor:
Sujun Han, Zhigang Ji, Junhui Jiang, Xinrong Fan, Qi Ma, Linjun Hu, Wen Zhang, Hao Ping, Jiansong Wang, Wanhai Xu, Benkang Shi, Wei Wang, Haifeng Wang, Honglei Wang, Shouzhen Chen, Hailong Hu, Jianming Guo, Shen Zhang, Shuai Jiang, Quan Zhou, Nianzeng Xing
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12106-12117 (2023)
Abstract Background Neoadjuvant chemotherapy followed by radical cystectomy (RC) is the standard of care for patients with muscle‐invasive bladder cancer (MIBC). However, treatment outcomes are suboptimal. Camrelizumab, a PD‐1 blockade, has shown
Externí odkaz:
https://doaj.org/article/fe15d6a17f1f45e980af3613837446e1
Autor:
Sujun Han, Taoping Shi, Yuchen Liao, Dong Chen, Feiya Yang, Mingshuai Wang, Jing Ma, Hu Li, Yu Xu, Tengfei Zhu, Wenxi Chen, Guoqiang Wang, Yusheng Han, Chunwei Xu, Wenxian Wang, Shangli Cai, Xu Zhang, Nianzeng Xing
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Prostate cancer is one of the most common cancers in men with notable interpatient heterogeneity. Implications of the immune microenvironment in predicting the biochemical recurrence-free survival (BCRFS) after radical prostatecto
Externí odkaz:
https://doaj.org/article/1d2ca882fd3a460e9dc593858ada754a
Autor:
Fei Liu, Zixian Wang, Xiaofan Li, Zhen Zhang, Yue Yang, Junquan Chen, Dinghua Chen, Lingling Wu, Xiangyu Liu, Sujun Han, Fangming Wang, Wasilijiang Wahafu, Yibo Gao, Shancheng Ren, Nianzeng Xing, Guangyan Cai, Xiangmei Chen
Publikováno v:
Cancer Communications, Vol 43, Iss 2, Pp 214-224 (2023)
Abstract With the development and introduction of immune checkpoint inhibitors (ICIs) in cancer patients, immune‐related side effects have increasingly attracted attention. However, the risks of immune‐related renal toxicity are poorly characteri
Externí odkaz:
https://doaj.org/article/9d04ad5b092a44c9acac44901ff6347a
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background With the development of minimally invasive technology, more and more people pay attention to aesthetics of the wound after operation. This study is aim to introduce a new surgical technique of transvaginal natural orifice specimen
Externí odkaz:
https://doaj.org/article/2b4429937a34498382bef08faa678525
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
PurposeTo investigate the relationship between baseline clinicopathological and laboratory variables especially hematological parameters and lymphovascular invasion (LVI) in patients who underwent radical prostatectomy (RP).MethodsWe retrospectively
Externí odkaz:
https://doaj.org/article/de36cb0b4be94f1b9ec9c308b076e2d1
Autor:
Fei Liu, Xiaolei Shi, Fangming Wang, Sujun Han, Dong Chen, Xu Gao, Linhui Wang, Qiang Wei, Nianzeng Xing, Shancheng Ren
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and objectivesProstate specific antigen (PSA) is currently the most commonly used biomarker for prostate cancer diagnosis. However, when PSA is in the gray area of 4-10 ng/ml, the diagnostic specificity of prostate cancer is extremely low,
Externí odkaz:
https://doaj.org/article/ee6e84afa19147c0b7e5a9e8e5e0b608
Autor:
Wen Kong, Tongtong Yang, Xiaodong Wen, Zhongyi Mu, Cheng Zhao, Sujun Han, Jing Tian, Xinhao Zhang, Tao Zhou, Yanrui Zhang, Feng Lou, Shanbo Cao, Huina Wang, Jin Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRenal cell carcinoma (RCC) is a disease of genomic alterations, of which the complete panorama helps in facilitating molecular-guided therapy. Germline mutation profiles and associated somatic and clinical characteristics remains unexplored
Externí odkaz:
https://doaj.org/article/2c8e8e86d9754e66a2e676592b8c377c
Autor:
Dong Chen, Yaqin Wang, Feiya Yang, Adili Keranmu, Qingxin Zhao, Liyuan Wu, Sujun Han, Nianzeng Xing
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
An increasing number of studies have shown that circRNAs are closely related to the carcinogenesis and development of prostate cancer (PCa). However, little is known about the effect of the biological functions of circRNAs on the enzalutamide resista
Externí odkaz:
https://doaj.org/article/a82719dc38454164afc29a5855342ada